BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
Matthew S. Zabriskie(University of Utah), Christopher A. Eide(Howard Hughes Medical Institute), Srinivas K. Tantravahi(University of Utah), Nadeem A. Vellore(University of Utah), Johanna Estrada(University of Utah), Franck E. Nicolini(Inserm), H. Jean Khoury(Emory University), Richard A. Larson(University of Chicago), Marina Konopleva(The University of Texas MD Anderson Cancer Center), Jörge E. Cortes(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Jeffrey H. Lipton(University of Toronto), Delphine Réa(Hôpital Saint-Louis), Leif Stenke(Karolinska University Hospital), Gisela Barbany(Karolinska Institutet), Thoralf Lange, Juan Carlos Hernández‐Boluda(Hospital Clínico Universitario de Valencia), Gert J. Ossenkoppele(Amsterdam UMC Location Vrije Universiteit Amsterdam), Richard D. Press(Oregon Health & Science University), Charles Chuah(Singapore General Hospital), Stuart L. Goldberg(Hackensack University Medical Center), Meir Wetzler(Roswell Park Comprehensive Cancer Center), François-Xavier Mahon(Inserm), Gabriel Étienne(Institut Bergonié), Michele Baccarani(University of Bologna), Simona Soverini(University of Bologna), Gianantonio Rosti(University of Bologna), Philippe Rousselot, Ran Friedman(Linnaeus University), Marie Deininger(University of Utah), Kimberly R. Reynolds(University of Utah), William L. Heaton(University of Utah), Anna M. Eiring(University of Utah), Anthony D. Pomicter(University of Utah), Jamshid S. Khorashad(University of Utah), Todd W. Kelley(University of Utah), Riccardo Baron(University of Utah), Brian Druker(Howard Hughes Medical Institute), Michael W. Deininger(University of Utah), Thomas O’Hare(University of Utah)
Cited by 365Open Access
Abstract
Related Papers
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL
Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle et al.|New England Journal of Medicine|2006|1.3k
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Mohammad Azam, Markus A. Seeliger, Nathanael S. Gray et al.|Nature Structural & Molecular Biology|2008|416